课题基金 / 基金详情

Control of growth and differentiation of normal and malignant human pluripotent stem cells

Control of growth and differentiation of normal and malignant human pluripotent stem cells
控制正常和恶性人类多能干细胞的生长和分化
批准号:
nhmrc : 194300
负责人:
Prof Martin Pera
金额:
$32.18万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2002
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2002-01-01 至 2004-12-31

项目摘要

项目成果

Prof Martin Pera的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human embryonic stem cells (ES cells) are cells derived from the early embryo which can be grown in culture for indefinite periods in the primitive embryonic state, while retaining a key feature of the embryonic cells from which they were derived: pluripotentiality, or the ability to give rise to any type of adult tissue cell. Because ES cells represent an unlimited source of any type of human cell, they have great potential for use in research areas such as functional genomics and drug discovery, and in regenerative medicine, the use of transplanted tissue to cure degenerative disease. Our laboratory is one of two in the world to develop human ES cells and the first to demonstrate differentiation of these cells into specialised cells-neurons- in vitro. In order to use ES cells, we need to learn more about how to grow and manipulate them in the laboratory, and how to turn them into desired types of somatic cell. Our study is based on the hypothesis that growth control in human ES cells resembles growth control in the embryo, with interactions between stem cells and their differentiated offspring mediated by signals from membrane bound or soluble proteins directing the differentiation of the stem cells. We have recently identified several key protein regulators of human ES cells. This project will use high throughput analysis of gene expression to pinpoint more candidate regulatory proteins. Then we will use cell culture systems and techniques developed in our laboratory to determine how these proteins may act to control stem cell growth. These studies will result in a greatly improved ability to control stem cells and turn them into specialised cell types for use in research and regenerative medicine. These advances are essential if ES cells are to progress from their current status as an interesting laboratory phenomenon to become a powerful tool for research and medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modelling epileptic encephalopathies using induced stem cells
  • 批准号:
    nhmrc : 1106027
  • 项目类别:
    Project Grants
  • 资助金额:
    $34.71万
  • 财政年份:
    2016
  • 负责人:
    Prof Martin Pera
  • 依托单位:
Modelling epileptic encephalopathies using induced stem cells
  • 批准号:
    nhmrc : GNT1106027
  • 项目类别:
    Project Grants
  • 资助金额:
    $50.65万
  • 财政年份:
    2016
  • 负责人:
    Prof Martin Pera
  • 依托单位:
REGULATION OF HUMAN MULTIPOTENT STEM CELLS BY MEMBRANE BOUND AND SOLUBLE FACTORS
  • 批准号:
    nhmrc : 990395
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $23.27万
  • 财政年份:
    1999
  • 负责人:
    Prof Martin Pera
  • 依托单位:
国内基金
海外基金
基于FP-Growth关联分析算法的重症患者抗菌药物精准决策模型的构建和实证研究
  • 批准号:
    2024Y9049
  • 项目类别:
    省市级项目
  • 资助金额:
    100.0万元
  • 批准年份:
    2024
  • 负责人:
    阮君山
  • 依托单位:
含Re、Ru先进镍基单晶高温合金中TCP相成核—生长机理的原位动态研究
  • 批准号:
    52301178
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    夏万顺
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
基于 Klotho 调控 FGF23/SGK1/NF-κB信号通路研究糖尿病肾病血管钙化机制及肾元颗粒干预作用
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
  • 依托单位: